Aarey Drugs & Pharmaceuticals Limited — Board Meeting, 04-12-2024: Outcome of Board Meeting

The Board of Directors of Aarey Drugs and Pharmaceuticals Limited has approved the issuance of up to 50,00,000 warrants convertible into equity shares on a preferential basis, pending approval from shareholders at the upcoming Extraordinary General Meeting (EGM) scheduled for January 2, 2025. The Board also reappointed Mr. Lalit Radha Krishna Tulsiani and Mr. Anil Mandal as Independent Directors for an additional five-year term, subject to shareholder approval. The EGM notice and related documents have been prepared for distribution to the members.